Bank of New York Mellon’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.5M | Buy |
|
|||||
|
2025
Q2 | $4.33M | Buy |
|
|||||
|
2025
Q1 | $5.19M | Sell |
|
|||||
|
2024
Q4 | $5.64M | Buy |
|
|||||
|
2024
Q3 | $3.34M | Sell |
|
|||||
|
2024
Q2 | $3.33M | Buy |
|
|||||
|
2024
Q1 | $3.5M | Buy |
|
|||||
|
2023
Q4 | $1.66M | Buy |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $1.29M | Buy |
|
|||||
|
2023
Q1 | $738K | Sell |
|
|||||
|
2022
Q4 | $869K | Buy |
|
|||||
|
2022
Q3 | $927K | Buy |
|
|||||
|
2022
Q2 | $651K | Buy |
|
|||||
|
2022
Q1 | $423K | Sell |
|
|||||
|
2021
Q4 | $569K | Buy |
|
|||||
|
2021
Q3 | $529K | Buy |
|
|||||
|
2021
Q2 | $625K | Buy |
|
|||||
|
2021
Q1 | $499K | Sell |
|
|||||
|
2020
Q4 | $761K | Buy |
|